Enhancement of contextual fear-conditioning by putative (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-d-aspartate (NMDA) receptor antagonists in DBA/2J mice-Reference-Cited by-同舟云学术

Enhancement of contextual fear-conditioning by putative (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-d-aspartate (NMDA) receptor antagonists in DBA/2J mice

Published:1997-09 Issue:1-2 Volume:768 Page:197-207
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Lu Ying,Wehner Jeanne M

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference58 articles.

1. Spatial learning and memory, maze running strategies and cholinergic mechanisms in two inbred strains of mice;Ammassari-Teule;Behav. Brain Res.,1985

2. Prevention by the NMDA receptor antagonist, MK801, of neuronal loss produced by tetanus toxin in the rat hippocampus;Bagetta;Br. J. Pharmcol.,1990

3. Z.I. Bashir, N. Berretta, Z.A. Bortolotto, K. Clark, C.H. Davies, B.G. Frenguelli, J. Harvey, B. Potier, G.L. Collingridge, NMDA receptors and long-term potentiation in the hippocampus, in: G.L. Collingridge, J.C. Watkins (Eds.), The NMDA Receptor, Oxford University Press, 1994, pp. 294–312.

4. Oxiraxetam prevents the hippocampal cholinergic hypofunction induced by the NMDA receptor blocker AP7;Belfiore;Neurosci. Lett.,1992

5. 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases;Bonta;Br. J. Pharmacol.,1971

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Control of Theta Oscillatory Activity Underlying Fear Expression by mGlu5 Receptors;Cells;2022-11-10

2. Adult and adolescent C57BL/6J and DBA/2J mice are differentially susceptible to fear learning deficits after acute ethanol or MK-801 treatment;Behavioural Brain Research;2021-07

3. Oral aniracetam treatment in C57BL/6J mice without pre-existing cognitive dysfunction reveals no changes in learning, memory, anxiety or stereotypy;F1000Research;2018-06-22

4. Oral aniracetam treatment in C57BL/6J mice without pre-existing cognitive dysfunction reveals no changes in learning, memory, anxiety or stereotypy;F1000Research;2017-12-15

5. Study of oral aniracetam in C57BL/6J mice without pre-existing cognitive impairments;F1000Research;2017-08-14